Dr James Wilson - Lung Cancer Specialist UK

Dr James Wilson - Lung Cancer Specialist UK Stop waiting. Get clarity from a leading UK lung cancer specialist. Fast access to personalised treatment for all stages. End the uncertainty and take control.

Book a consultation within 48 hours - expert answers, honest options, personal care. Dr James Wilson is a London-based private oncologist with expertise in lung cancer, skin cancer, and advanced radiotherapy for Stage 4 cancers. He offers rapid access to chemotherapy, immunotherapy, targeted therapy, and precision radiotherapy - including proton beam therapy. Known for clear communication and personalised care, Dr Wilson helps patients take control with expert second opinions and tailored treatment plans. Appointments are often available within days, either in person or via video. Video consultations are often possible on the same or next day. Trusted by patients
Specialist in complex and advanced cases
Precision-led, consultant-delivered care

02/01/2026

Just been diagnosed with lung cancer and hearing about radiotherapy?

Here's what it actually means.

Radiotherapy uses focused beams of high-energy X-rays to destroy cancer cells by targeting them at a cellular level.

These beams damage the DNA inside cancer cells, stopping them from dividing and growing.

Healthy cells around the tumour are affected too, but here's the crucial difference: normal cells are far better at recovering from radiation damage than cancer cells.

That's why radiotherapy for lung cancer is divided into multiple fractions. By delivering small doses daily over weeks, we accumulate irreparable damage in cancer cells whilst giving normal tissues time to heal between treatments.

This therapeutic window is what makes radiotherapy effective and tolerable.

Radiotherapy is used in approximately half of all cancer patients.

It's one of our most trusted treatments for lung cancer, whether aiming for cure, local control of the disease, or relief of symptoms.

It's powerful, precisely targeted, and backed by decades of clinical evidence in lung cancer treatment.

Over this series, we'll cover everything involved in lung cancer radiotherapy, from planning to delivery to what you can expect.

- - -

Facing a lung cancer diagnosis? Here are the clear, simple steps that come next.Why so many tests?It’s natural to want t...
21/12/2025

Facing a lung cancer diagnosis? Here are the clear, simple steps that come next.

Why so many tests?

It’s natural to want treatment immediately. But these tests aren’t delays, each one answers a critical question about your specific cancer.

This is precision, not over-testing.

1. CT Scan

Shows where the tumour is, how large, and how it interacts with surrounding tissues. It’s painless, just a few minutes.

2. PET Scan

Reveals how active the cancer is and if it’s spread to lymph nodes or bones. It tells us if treatment needs to be local or systemic.

3. Brain MRI

Checks for silent spread to the brain. If clear, we proceed with the main plan. If not, we treat it effectively.

4. Biopsy

Identifies whether it’s small cell or non-small cell lung cancer, and finds gene mutations like EGFR or ALK. This matches you to targeted therapy or immunotherapy.

5. Lung Function Tests

Determines if your lungs can handle surgery or radiotherapy safely.

Then everything comes together.

With all results, your multidisciplinary team - surgeons, oncologists, respiratory physicians, radiologists - reviews everything together and creates your personalised treatment plan.

This comprehensive lung cancer diagnostic pathway ensures we get your treatment right from the start.

If you or a loved one would like to discuss diagnosis or treatment pathways, drop me a DM or an email and let’s find some time to chat.

- - -

16/12/2025

You have stage III EGFR-positive lung cancer. You’ve just finished six weeks of radiotherapy with chemotherapy. Now you’re being told you need Osimertinib as well. Why?

The LAURA trial looked at giving Osimertinib after chemoradiotherapy for stage III EGFR-positive lung cancer.

The results were significant. Patients receiving Osimertinib after completing chemoradiotherapy were much less likely to experience cancer recurrence.

Crucially, Osimertinib consolidation therapy dramatically reduced brain metastases in stage III EGFR lung cancer patients.

Brain mets matter enormously: the brain is where we think, feel, and exist as ourselves.

Preventing brain metastases from EGFR lung cancer preserves not just survival, but quality of life and who you are.

This consolidation treatment with Osimertinib after chemoradiotherapy for stage III lung cancer isn’t just about treating existing cancer. It’s about protecting you and preventing problems before they start.

Think of Osimertinib consolidation therapy as insurance after you’ve done the hard work of chemoradiotherapy for stage III EGFR-positive lung cancer.

The LAURA trial showed this approach works, it’s evidence-based protection.

If you’ve recently finished chemoradiotherapy for stage III EGFR-positive lung cancer and consolidation targeted therapy hasn’t been discussed, that’s worth exploring with your oncology team.

- - -

15/12/2025

Is lung cancer curable? A question I get asked daily.

If you or someone you love has symptoms of lung cancer or are facing a possible diagnosis, this video explains every test you will go through.

CT, PET, MRI, biopsies and lung function tests all help answer one question: how treatable or curable is your lung cancer?

Before treatment begins, your team needs to understand where the cancer is, what type it is and what is driving it. Lung cancer diagnosis is not about doing unnecessary tests. It is about precision. Each scan and biopsy answers a different question and together they build a complete roadmap for your treatment plan.

In this video I cover:

- CT scan for lung cancer
What it shows, how it works and why it is usually the first step.

- PET scan for lung cancer staging
How cancer cells use sugar, how PET detects active disease and why it helps reveal hidden spread.

- MRI brain scan
Why the brain is scanned even if you feel well, what the MRI checks for and how the test works.

- Lung cancer biopsies
CT guided biopsies, EBUS, liquid biopsies and how they identify the exact cancer type.

- Molecular testing
EGFR, ALK and other mutations that guide targeted therapy and immunotherapy.

- Lung function tests
Why they matter for choosing between surgery, radiotherapy or other treatments and how the test keeps your cancer care safe.

These results help your team answer key questions about curability, early stage lung cancer prognosis and which treatment offers you the best chance of success.

Once all tests are complete, specialists from surgery, oncology, respiratory medicine and radiology sit together to finalise your plan. You will usually receive your results and recommendations within a few days.

If you are currently waiting for lung cancer results, know that every step is designed to avoid delays and to give you a clear and confident path forward.

For rapid access appointments, second opinions or further guidance, drop me a DM

- - -

13/12/2025

You’ve been diagnosed with EGFR-positive lung cancer and just found out it’s spread. What are your treatment options now?

In metastatic EGFR-positive lung cancer, we typically start with Osimertinib, a once-daily tablet you take at home that’s usually well tolerated.

But there’s more to the strategy than just tablets.

If scans show spread to your brain or other sites, we consider combining Osimertinib with radiotherapy upfront. This isn’t one-size-fits-all.

Your treatment plan should be personalised to your specific situation.

The NORTHSTAR trial showed that targeting both the primary lung tumour and sites of spread with radiotherapy alongside Osimertinib can extend survival on treatment. The average benefit was around eight months, that’s meaningful time.

This approach isn’t just treatment, it’s a comprehensive strategy designed specifically for advanced EGFR-positive lung cancer. It gives you time, control, and realistic hope.

If you’ve started targeted therapy for metastatic EGFR lung cancer but haven’t discussed radiotherapy planning yet, that’s worth exploring with your oncology team.

Understanding all your treatment options for EGFR-positive lung cancer matters. You shouldn’t be working this out alone.

- - -

12/12/2025

You’ve been diagnosed with EGFR-positive lung cancer and just found out it’s spread.

What are your treatment options now?

In metastatic EGFR-positive lung cancer, we typically start with Osimertinib, a once-daily tablet you take at home that’s usually well tolerated.

But there’s more to the strategy than just tablets.

If scans show spread to your brain or other sites, we consider combining Osimertinib with radiotherapy upfront. This isn’t one-size-fits-all.

Your treatment plan should be personalised to your specific situation.

The NORTHSTAR trial showed that targeting both the primary lung tumour and sites of spread with radiotherapy alongside Osimertinib can extend survival on treatment. The average benefit was around eight months, that’s meaningful time.

This approach isn’t just treatment, it’s a comprehensive strategy designed specifically for advanced EGFR-positive lung cancer. It gives you time, control, and realistic hope.

If you’ve started targeted therapy for metastatic EGFR lung cancer but haven’t discussed radiotherapy planning yet, that’s worth exploring with your oncology team.

Understanding all your treatment options for EGFR-positive lung cancer matters. You shouldn’t be working this out alone.

- - -

11/12/2025

EGFR-positive lung cancer has a weakness we can exploit with targeted treatment.

Drugs like Osimertinib are tablets you take at home that go directly after that specific vulnerability in your cancer cells.

EGFR targeted therapy for lung cancer often works far better than standard chemotherapy, with fewer side effects.

It’s still a serious lung cancer diagnosis, but EGFR-positive lung cancer behaves differently and responds to treatment in ways other lung cancers don’t.

Think of it like having satnav for your lung cancer treatment instead of that crumpled map in the boot.

We’re not guessing, we’re targeting precisely what’s driving your cancer.

This is one of the genuine success stories in modern lung cancer treatment.

EGFR mutations in lung cancer gave us a target where targeted therapy for lung cancer makes a measurable, real difference to outcomes and quality of life.

You’re not powerless in this. The biology of your EGFR-positive lung cancer actually gives us leverage.

If you’ve recently been diagnosed with EGFR-positive lung cancer or you’re on EGFR treatment and wondering what else is possible, speak to your oncology team about all your targeted therapy options for lung cancer.

- - -

10/12/2025

Not all lung cancers behave the same way. If you’ve just been diagnosed with lung cancer, some genetic changes actually work in your favour.

EGFR mutation in lung cancer is one of those changes. It’s found in certain lung adenocarcinomas, and whilst it’s part of what caused the cancer, it creates a vulnerability we can target.

Testing positive for EGFR in your lung cancer diagnosis means targeted pills instead of chemotherapy.

These tablets go straight after what’s driving your cancer’s growth - precision treatment based on your cancer’s specific biology.

Think of it this way: treating most lung cancers is like trying to break into a locked house in the dark.

An EGFR-positive lung cancer? Someone just handed us the key.

It sounds odd to call any lung cancer mutation “better,” but that’s what this is.

EGFR-positive lung cancer gives us a clear target and effective targeted therapy options that genuinely work.

This lung cancer test result isn’t just a classification, it’s your personalised treatment roadmap.

If you’ve just received your lung cancer diagnosis with EGFR mutation and everything feels overwhelming, talk to your oncology team about targeted treatment options.

- - -

07/12/2025

If your diagnosed with lung cancer, your treatment will depend entirely on understanding what type of lung cancer you have and what’s driving it.

That requires getting a sample.

We can take tissue directly from the tumour, or analyse cancer DNA circulating in your blood. Both give us what we need.

How we get the sample:
1. CT-guided biopsy: Local anaesthetic, then a needle inserted into the tumour under CT guidance to extract tissue.
2. EBUS: A camera passed into your airways to sample lymph nodes or tumours close to the airway.
3. Liquid biopsy: If tissue sampling isn’t possible, a simple blood test can detect the cancer’s genetic signature in your bloodstream.

What we’re looking for:
Whether this is small cell or non-small cell lung cancer. Gene mutations like EGFR or ALK that make you eligible for targeted therapies. Markers that predict response to immunotherapy.

This is precision treatment, matching you to the therapy most likely to work for your specific cancer.

One final test before we finalise your plan: checking how well your lungs are functioning.

- - -

03/12/2025

The appointments start coming in. Scans, tests, biopsies.

And the question everyone asks: Why do I need so many when I just want to start treatment?

Here’s what those tests are actually doing:
It’s not just about confirming you have lung cancer. It’s about understanding YOUR specific cancer.

Each test answers a different question:
- What type is it?
- Where exactly is it?
- Has it spread?
- What are the genetic markers?
- Can surgery help?
- Which treatment will work best?

Your CT scan shows us the size and location.
Your biopsy tells us the cancer type and biology.
Your PET scan reveals if it’s travelled.
Your lung function tests check if you can tolerate treatment.

Together, they build a complete roadmap of your treatment plan.

I know it feels like delays when you want to start immediately. But these tests are happening quickly and strategically. We’re arranging them close together, often on the same day where possible, to get you to the right treatment without wasting time on the wrong one.

When we start your treatment, we want full confidence we’re heading in the right direction.

Speed matters. But precision matters more.

In the next few videos, I’ll walk you through each test in detail, starting with the CT scan.

01/12/2025

Lung cancer diagnosis is changing fast. Here’s where we’re heading.

As a lung cancer specialist, I’m watching the future of diagnosis unfold right now. And it’s genuinely exciting.

My vision for the next few years:
→ Same-day diagnostic clinics where all your tests happen at once
→ Liquid biopsies that replace needles: a simple blood test instead of invasive procedures
→ AI-powered screening results delivered before you even have symptoms
→ Ultra-low radiation scans with higher accuracy than ever before

The result? Faster answers. Less invasive tests. Earlier treatment. More lives saved.

Lung cancer diagnosis services are already miles better than they were five years ago. But we’re not stopping there.

Here’s what you need to know right now:
With lung cancer, speed matters. Don’t wait for symptoms to appear.

If you’re eligible for screening, attend. Early detection is your best chance.

If you have lung cancer, get all your tests done as quickly as possible so treatment can start straight away.

The future of lung cancer diagnosis is faster, smarter and less invasive. But the best tool we have today is still early detection.

- - -

Address

Services Available In:
London
SW50TU

Opening Hours

Monday 8am - 6pm
Tuesday 8am - 6pm
Wednesday 8am - 6pm
Thursday 8am - 6pm
Friday 8am - 6pm

Telephone

+442079936716

Website

Alerts

Be the first to know and let us send you an email when Dr James Wilson - Lung Cancer Specialist UK posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Dr James Wilson - Lung Cancer Specialist UK:

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category